STAAR Surgical’s NanoFLEX™ Collamer® IOL Receives CE Mark Approval
STAAR Surgical Company , a leading developer, manufacturer and marketer of minimally invasive ophthalmic products, today announced CE Mark approval for its nanoFLEXT Collamer® Single Piece IOL which can be injected through a 2.2 mm incision with the nanoPOINT Injector System. The nanoFLEX IOL incorporates the Company's proprietary aspheric optic design (patent pending), which is optimized for the naturally curved anatomy of the eye. CE Mark approval allows the Company to market nanoFLEX in the European Economic Area (EEA) and can serve as a foundation for some additional approvals in (Read more...)